AI-driven cardiometabolic and diabetes digital health platform
Welldoc builds clinically validated AI for cardiometabolic and diabetes care, and its stack has shifted hard toward generative AI: GPT-4, Llama, LangGraph, CrewAI and AutoGen sit alongside vector stores like Pinecone, Weaviate and FAISS. Explainability tools (SHAP, LIME) plus job-post focus on red teaming, drift monitoring and AI regulatory compliance show a team hardening LLM agents for regulated clinical use. A new business development head and India GTM work signal geographic expansion.
Notable leadership hires: Business Development Head
Welldoc is a privately held digital health company headquartered in Columbia, Maryland, founded in 2005, with 51–200 employees. It offers an AI platform that turns cardiometabolic data into personalized, predictive guidance for members, care teams and healthcare partners. Core areas include diabetes self-management, automated patient coaching, clinical decision support and behavioral science. The company runs on Azure and AWS with Databricks and Apache Spark for data work, and uses Salesforce Marketing Cloud and Pardot for marketing. It hires in the United States and India.
Welldoc uses Python, GPT-4, Llama, LangChain, LangGraph, CrewAI and AutoGen, vector databases Pinecone, Weaviate and FAISS, plus Azure, AWS, Databricks, Apache Spark and SQL Server.
Welldoc is headquartered in Columbia, Maryland, United States, and also hires in India.
Job posts point to scalable RAG pipelines, autonomous agent workflows, AI red teaming, drift detection, golden set management and a go-to-market strategy for its healthcare IT suite in India.
Other companies in the same industry, closest in size
Welldoc's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →
This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.